GlassScriptBenchmark
Payments companies reported to CMS as associated with Benchmark. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Benchmark, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Benchmark
These are the largest totals companies reported as associated with Benchmark. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Sahlein | Carmel, IN | Vascular & Interventional Radiology | $14,972.25 |
| Thinesh Sivapatham | Newark, DE | Diagnostic Radiology | $13,614.87 |
| Jeffrey Beecher | Wilmington, NC | Neurological Surgery | $11,707.33 |
| Sudhakar Satti | Paoli, PA | Neuroradiology | $10,127.21 |
| Robert Starke | Miami, FL | Neurological Surgery | $7,897.74 |
| Vasu Saini | Miami Beach, FL | Vascular & Interventional Radiology | $7,861.14 |
| Justin George | New York, NY | Vascular Surgery | $4,800.00 |
| Ankur Garg | Winter Park, FL | Neurology (Psychiatry & Neurology) | $3,784.37 |
| Aws Alawi | Seattle, WA | Neurology (Psychiatry & Neurology) | $3,691.76 |
| John Chaloupka | Miami Beach, FL | Vascular & Interventional Radiology | $3,512.98 |
Prescribed Benchmark?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.